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Abstract
Oral Lichen Planus (OLP) is a common chronic inflammatory disease, 
which involves the mucous membranes of the oral cavity, with an overall age-
standardized prevalence of 1.27% (0.96% in men and 1.57% in women) as reported 
in the literature by McCartan and Healy. In our previous work, we exploited a 
bioinformatics approach, namely the Leader Gene Algorithm (LGA), enabling 
to underpin the main hub genes (termed as Leader Genes) involved in biological 
processes. In the case of OLP, we found a complex network made up of 132 
genes and, in particular, we found five Leader Genes (namely, JUN, EGFR, FOS, 
IL2, and ITGB4). Using a subsequent bioinformatics algorithm, we managed to 
find the 48.39% of the already established OLP-related microRNAs (miRNAs), 
suggesting that at least half of the OLP-related microRNAome (miRNAome) 
finely tunes few, highly interconnected hub genes. Now, we would use real 
clinical samples in order to validate our predicted biomarkers, using molecular 
biology techniques, mass-spectrometry (MS) and ad hoc in-house developed 
instruments, such as Nanoconductimetry via Quartz Crystal Microbalance with 
Dissipation factor monitoring (QCM_D). A unique combination of genomics 
and proteomics approaches can indeed represent a promising innovation for a 
personalized treatment of OLP and oral cancer.
Keywords
Nanogenomics and the Leader Gene Algorithm (LGA), Oral Lichen Planus 
(OLP) as translational model of oral cancer, Quartz Crystal Microbalance with 
Dissipation Factor monitoring (QCM_D) and Nanoconductimetry, SNAP 
microarrays, Mass spectrometry (MS)
Introduction
Oral Lichen Planus (OLP) is a common chronic inflammatory disease 
[1], which involves the mucous membranes of the oral cavity, with an overall 
age-standardized prevalence of 1.27% (0.96% in men and 1.57% in women), as 
reported in the literature by McCartan and Healy [2].
The histopathological features of OLP are hydropic degeneration of the 
basal cell layer, hyperkeratosis, acanthosis, irregular ridges and a dense band-
like infiltration of T lymphocytes mainly in the lamina propria. Although the 
aetiology of OLP is still unknown, it has been widely accepted that immunological 
impairments are very critical among the multiple aetiological factors. Previous 
studies have suggested that it may represent a cell-mediated immunologic 
response to an induced antigenic change in the oral mucosa [3, 4].
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Evidence concerning EGFR regulation is indeed controversial 
and not conclusive. Moreover, the Leader Genes were widely 
distributed in the network (in term of topological parameters, 
such as stress, eccentricity and radiality) and showed higher 
topological coefficients than the other genes.
Bioinformatics Section
In the current work, in order to predict the potential 
microRNAs (miRNAs) network related to OLP, we used 
our previously identified “Leader Genes”, namely both the 
Class A genes ( JUN, EGFR, FOS, IL2, and ITGB4) and the 
Class B genes (CASP3, CD247, IL2RA, IFNG, MMP2 and 
LAMC2). 
Genetic and genomics research is rapidly increasing our 
understanding of the molecular basis of some diseases and may 
also suggest new diagnostic and treatment strategies, paving 
the way for technological and industrial innovations. Many 
oral diseases are complex, multifactorial disorders and, as such, 
have a genetic basis. Studies of these pathological conditions 
suggest that multiple gene interactions are important 
determinants of susceptibility.
miRNAs are a family of small and short (usually 19-25 
nucleotides long), single-stranded, endogenous, non-coding 
RNA molecules. They play a key role both in physiology and 
in pathology, and their role in pathogenesis of oral diseases is 
emerging. However, despite the importance of incorporating 
the oral microRNAome (miRNAome) in the study of oral 
disorders, so far only few miRNAs related to them have been 
discovered and described in the literature. For this reason, we 
predicted OLP-related miRNAs.
This could accelerate research in the field, stimulating 
researchers to test and verify our hypothesis and comparing 
wet-lab findings with computational predictions.
Then, we mined the miRGen database using the “Targets” 
option (freely available at http://www.microrna.gr/mirgen). 
This software relies on a relational database technology 
and enables a comprehensive research, integrating both the 
most widely used databases and repositories with the list of 
experimentally validated miRNAs and the bioinformatics 
tools for the miRNAs prediction (namely, DIANA-microT, 
miRanda, miRBase, PicTar, and TargetScanS) [12, and 
references therein]. We checked the biological significance 
of our obtained miRNAs networks mining the extant 
literature and using ad hoc bioinformatics tools (such as the 
miR2Disease Base, freely accessible at http://watson.compbio.
iupui.edu:8080/miR2Disease/searchDiseasePre.jsp) [12, and 
references therein]. 
In order to verify the statistical significance of the 
enrichment of our miRNA-related list, we randomly generated 
a list of 11 genes (5 for Class 1 and 6 for Class 2). We used the 
RSA tool for this purpose (freely accessible at http://rsat.ulb.
ac.be/rsat/random-genes_form.cgi), selecting “Homo sapiens” 
as source organism. 
Using the above-mentioned tools we generated a network 
of miRNAs associated to the obtained list of random genes. 
In our previous work [5], we exploited a bioinformatics 
approach, namely the Leader Gene Algorithm (LGA), 
enabling to underpin the main hub genes (termed as Leader 
Genes) involved in biological processes. Only human genes 
were considered. In this way, it was possible to identify a list of 
candidate genes potentially involved in OLP pathogenesis, by 
mining different genomics databases and datasets. 
The preliminary set of genes was then expanded using 
the web-available software STRING (version 9.1, freely 
available at http://string-db.org/) [6], considering only direct 
interactions (i.e. physical contact between encoded proteins, 
gene expression microarray data, or direct linkage in the 
same pathway), with a high degree of confidence (above 0.9 
– confidence value in STRING ranges between  0 and 0.99, 
with 0.99 being the highest confidence). In this way, it is 
possible to identify new genes directly linked to those with 
an already established role in OLP, and therefore potentially 
involved in this disease. In order to discard false positives, 
results were then filtered using a further search in literature 
and gene databases. The process was repeated until no new 
gene potentially involved in OLP was identified. Then, an 
interaction map among the identified genes was calculated 
using STRING. This software can give a combined association 
score to each interaction, representing the degree of confidence 
for each interaction. For every gene identified, we summed the 
different combined association scores with the other genes. 
The sum of all these scores is defined as the weighted number 
of links (WNL). 
Genes were then clustered, using hierarchical or K-means 
algorithms, according to their WNL. The genes belonging to 
the highest rank are defined as Leader Genes; these genes 
have a significant higher WNL if compared with the other 
ones. The other ranks are termed class B, class C, class D genes 
and so on, according to their WNL scores. Genes with no 
identified interactions (i.e. WNL=0) are defined as orphan 
genes. Differences among various classes in terms of WNL 
were statistically evaluated using an Analysis of Variance 
(ANOVA) test, with a Tukey-Kramer test as post-hoc test. 
Statistical significance was set at a p-value < 0.001, in order to 
ensure a high level of data reliability. 
LGA was already successfully applied for investigating 
hub genes in different pathologies, such as periodontitis [7], 
dental diseases and their risk of malignant transformation [8, 
9], and kidney transplantation [10, 11], among others.
Moreover, interacting genes were classified as up-
regulated, down-regulated or neutral in respect to OLP 
pathogenesis. For neutral genes, we mean that they do not 
exhibit fold expression changes in the disease versus health 
control condition or genes for which there is not a universal 
consensus in the literature and in the databases.
In the case of OLP, we found a complex network made 
up of 132 genes and, in particular, we found five Leader 
Genes (namely, JUN, EGFR, FOS, IL2, and ITGB4). The 
interactions in the obtained network showed power law 
behavior, in good agreement with the scale-free topology 
theory of the biological graphs. 
Interestingly, all of them but EGFR were up-regulated. 
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The two miRNAomes were compared using the statistical test 
for comparing two proportions/percentages. This computation 
was done with the commercial software MedCalc (version 15, 
down-loadable at http://www.medcalc.org/) and using the R 
environment (freely available at http://www.r-project.org/).  
Topological properties of the obtained graphs portraying 
the OLP-related miRNAomes have been also studied. We 
investigated the clustering coefficient (a measure of degree to 
which nodes in a graph tend to cluster together), the network 
diameter and radius, the network centralization, the number 
of shortest paths (in percentage), the characteristic path 
length, the average number of neighbors, and the network 
density (the proportion of all the possible ties that are actually 
present). Network density reflects the speed at which signaling 
information diffuse among the nodes. 
All the parameters were studied using Cytoscape software 
(freely downloadable at http://sourceforge.net/projects/
graph-medusa/) [12, and references therein]. Networks are 
visualized using Medusa software [12, and references therein].
Results
miRNAs that have been already experimentally validated 
represent the 35.48% (11/31) of the entire list. Class A 
leader genes-related miRNAs predict the 54.17% (104/192) 
of the OLP + oral diseases-associated miRNAs validated in 
the literature. Compared to the related randomly generated 
miRNAome, the numbers of experimentally validated 
miRNAs did not statistically differ (9/31 versus 11/31), but 
the numbers of oral disease-associated miRNAs yielded a 
statistical significance (p-value < 0.05).
miRNAs that have been already found to be associated 
with OLP are the 32.26% (12/31) of the entire list, against 
9/31 for the randomly generated miRNAs (not statistically 
significant). Class B leader genes-related miRNAs predict 
the 46.03% (58/126) of the OLP + oral diseases-associated 
miRNAs validated in the literature. Taken together the 
Class A and Class B leader genes-related miRNAs, they can 
predict the 48.39% (15/31) of the OLP and the of OLP + oral 
diseases-associated miRNAs validated in the literature.
In Table 1, the topological properties of the OLP-related 
miRNAome are reported. The two sub-sets related to Class A 
and Class B Leader Genes are shown in Figure 1.
Here, in the current contribution, we introduced a novel 
biomolecular strategy for predicting diseases-related miRNAs, 
based upon our previous published LGA. We managed to 
find most of the already established OLP-related miRNAs. 
Moreover, we found also other miRNAs that have not been 
directly linked with OLP yet, but have a role in other oral 
diseases. For the remaining miRNAs their role is still unknown. 
This biomolecular strategy can foster further research 
in the field of the biology of oral diseases, suggesting to the 
researchers and molecular biologists some targets to focus on 
and to explore with ad hoc targeted experiments. Moreover, it 
may lead to new bioinformatics software for both commercial 
and academic applications.
Conclusions
These data could further confirm that an approach based 
on bioinformatics and data-mining of existing databases could 
be a starting point to improve our knowledge about cellular 
processes and molecular mechanism of diseases and to plan 
targeted experimentation. In particular, the detailed analysis 
of gene interaction maps and the ranking of genes according 
to their number and confidence of interactions might have 
great value in the identification of new targets for a focused 
experimental analysis, which may confirm each hypothesis and 
Figure 1: Class A leader genes-related miRNAome (upper), class B leader 
genes-related miRNAome (lower). In red the OLP-related genes, in blue the 
OLP-related miRNAs.
Table 1: Comparison of the topological properties among the entire 















Clustering coefficient 0.19 0.96 0.73
Network radius 3 2 2
Network diameter 2 1 1
Network centralization 0.94 0.99 0.99




Average number of 
neighbors
41.49 5.78 7.70
Network density 0.04 0.01 0.01
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suggest potential risk factors and therapy targets. Noteworthy, 
a proper combination of experimental and theoretical results 
is necessary to draw a significant picture of a complex 
phenomenon, such as gene expression in a particular biologic 
system. In this study, some genes with a potential major role in 
OLP were identified and are preliminarily divided into three 
different groups according to their function. Their miRNAs 
are predicted and studied. These results might suggest targeted 
DNA or protein micro-arrays such as SNAP micro-arrays, as 
well as RT-PCR and mass spectrometry (MS) experiments 
and Nanoconductimetry via Quartz Crystal Microbalance 
with Dissipation factor monitoring (QCM_D) [13-15], 
focused on significant genes and simpler to be analyzed than 
mass scale molecular genomics. 
There are many relevant technological and industrial 
implications of our study: from the possibility of creating 
panels of salivary or serum biomarkers [16], or of using 
stem cell therapy delivering particular genes for healing oral 
mucosal lesions [17]. A unique combination of genomics 
and proteomics approaches can indeed represent a promising 
innovation for a unique personalized treatment of OLP and 
oral cancer [18].
This theoretical premise is unique for its potential clinical 
value, considering that the marginal (although significant) 
differences between randomly generated and experimentally 
validated miRNAs point to the critical importance of 
prospective validation in a patient cohort [19]. Assuming the 
prevalence rate reported in reference [2] in the range 1.27-
1.57% and a precision of 5%, a minimum number of 20-24 
patients, within the 95% confidence interval, is needed to 
validate our bioinformatics predictions. This will be the focus 
of a separated, ongoing, clinical assessment.
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